Performance of weighted estimating equations for longitudinal binary data with drop-outs missing at random.

abstract：:The identification of counties burdened by exceptionally high rates of mortality is a fundamental step in the development of state-based intervention and prevention strategies. However, the estimation of rates from small geographic areas presents special problems, especially for rare events. This paper compares the us...

journal_title：Statistics in medicine

authors： Stevenson JM,Olson DR

更新日期：1993-02-01 00:00:00

abstract：:Comparative studies of the accuracy of diagnostic procedures often use a paired design to gain in efficiency. Standard methods for analysing data from paired designs require complete observations. In many studies, however, one of the test results may be missing for some patients. In this paper, we propose a simple cor...

journal_title：Statistics in medicine

authors： Zhou XH,Gatsonis CA

更新日期：1996-08-15 00:00:00

abstract：:We propose a semiparametric method for estimating ROC surfaces for continuous diagnostic tests based on two test measurements. Such a three-class diagnostic problem based on two test measurements arises naturally from some DNA amplification-related diagnostic scenarios. Simulation results show that our proposed semipa...

journal_title：Statistics in medicine

authors： Wan S,Zhang B

更新日期：2009-08-15 00:00:00

abstract：:In genetic and genomic studies, gene-environment (G×E) interactions have important implications. Some of the existing G×E interaction methods are limited by analyzing a small number of G factors at a time, by assuming linear effects of E factors, by assuming no data contamination, and by adopting ineffective selection...

journal_title：Statistics in medicine

authors： Wu C,Shi X,Cui Y,Ma S

更新日期：2015-12-30 00:00:00

abstract：:Given N points or events occurring according to some probability distribution in the unit interval (0, 1), the simple scan statistic is defined to be the maximum number of points in any sub-interval of length d. In many areas, as in epidemiology, it is used to test the null hypothesis that the events are random, again...

journal_title：Statistics in medicine

authors： Nagarwalla N

更新日期：1996-04-15 00:00:00

abstract：:Frailty models are encountered in many medical applications, yet little research has been devoted to develop measures that quantify the predictive ability of these models. In this paper, we elaborate on the concept of the concordance probability to clustered data, resulting in an 'Overall Conditional C-index' or bfC(O...

journal_title：Statistics in medicine

authors： Van Oirbeek R,Lesaffre E

更新日期：2010-12-30 00:00:00

abstract：:In recent years, follow-on biological products (biosimilars) have received much attention from both the biotechnology industry and the regulatory agencies, especially after the passage of the 2010 healthcare reform bill. Unlike the traditional small-molecule drug products, the development of biological products is not...

journal_title：Statistics in medicine

authors： Yang J,Zhang N,Chow SC,Chi E

更新日期：2013-02-10 00:00:00

abstract：:In this paper statistical methods are proposed to estimate the distribution of a CD4 T-cell number at the time of a clinical AIDS endpoint from serial measurements of CD4 T-cell values in a cohort study. The statistical formulation of the problem is that of survival analysis with interval censored data, but in which t...

journal_title：Statistics in medicine

authors： Taylor JM,Kim DK

更新日期：1994-10-15 00:00:00

abstract：:This paper considers the effect of non-differential outcome misclassification on the population attributable fraction and the population prevented fraction. I examine the bias in the attributable and the prevented fraction derived from a risk ratio estimate as a function of the sensitivity and specificity of the outco...

journal_title：Statistics in medicine

authors： Hsieh CC

更新日期：1991-03-01 00:00:00

abstract：:In this paper, we consider fitting a flexible and interpretable additive regression model in a data-rich setting. We wish to avoid pre-specifying the functional form of the conditional association between each covariate and the response, while still retaining interpretability of the fitted functions. A number of recen...

journal_title：Statistics in medicine

authors： Petersen A,Witten D

更新日期：2019-02-20 00:00:00

abstract：:The incremental life expectancy, defined as the difference in mean survival times between two treatment groups, is a crucial quantity of interest in cost-effectiveness analyses. Usually, this quantity is very difficult to estimate from censored survival data with a limited follow-up period. The paper develops estimati...

journal_title：Statistics in medicine

authors： Titman AC

更新日期：2016-09-10 00:00:00

abstract：:Orthogonal polynomial scores (OPS) is a simple, biologically meaningful approach to characterize longitudinal data in phase I and II clinical pharmacology trials. It describes average, linear, quadratic and higher order polynomial characteristics of each subject's response over time with use of composite scores comput...

journal_title：Statistics in medicine

authors： Bradstreet TE

更新日期：1993-04-15 00:00:00

abstract：:In clinical research, investigators are interested in inferring the average causal effect of a treatment. However, the causal parameter that can be used to derive the average causal effect is not well defined for ordinal outcomes. Although some definitions have been proposed, they are limited in that they are not iden...

journal_title：Statistics in medicine

authors： Chiba Y

更新日期：2017-11-10 00:00:00

abstract：:Phase II and phase III trials play a crucial role in drug development programs. They are costly and time consuming and, because of high failure rates in late development stages, at the same time risky investments. Commonly, sample size calculation of phase III is based on the treatment effect observed in phase II. The...

journal_title：Statistics in medicine

authors： Kirchner M,Kieser M,Götte H,Schüler A

更新日期：2016-01-30 00:00:00

abstract：:When the accrual rate is low and the treatment period is long, a long observational period is required before information concerning the primary end point, such as binary response, becomes available in the study. Simon's two-stage designs are often employed in Phase II clinical trials to avoid giving patient an ineffe...

journal_title：Statistics in medicine

authors： Chi Y,Chen CM

更新日期：2008-12-20 00:00:00

abstract：:A three-component, competing-risk mortality model, developed for animal survival data, fits human life table data for all ages over a range of mean life spans from 16 to 74 years. The competing risks are a novel exponentially-decreasing hazard, dominant during immaturity; a constant hazard, dominant during adulthood; ...

journal_title：Statistics in medicine

authors： Siler W

更新日期：1983-07-01 00:00:00

abstract：:Clinical prediction models (CPMs) can inform decision making about treatment initiation, which requires predicted risks assuming no treatment is given. However, this is challenging since CPMs are usually derived using data sets where patients received treatment, often initiated postbaseline as "treatment drop-ins." Th...

journal_title：Statistics in medicine

authors： Sperrin M,Martin GP,Pate A,Van Staa T,Peek N,Buchan I

更新日期：2018-12-10 00:00:00

abstract：:Health surveillance involves collecting public health data on chronic and infectious diseases to detect changes in disease incidence rates in order to improve public health. Timely detection of disease clusters is essential in prospective public health surveillance. Most existing health surveillance research is based ...

journal_title：Statistics in medicine

authors： Jiang W,Han SW,Tsui KL,Woodall WH

更新日期：2011-02-28 00:00:00

abstract：:The construction, validation and updating of a prognostic model for kidney graft survival is reported using data from the Eurotransplant database. First, a model is constructed for data from transplantations in the period 1984 to 1987. The model is later updated for the 1988 1990 data. The first data set was randomly ...

journal_title：Statistics in medicine

authors： Van Houwelingen HC,Thorogood J

更新日期：1995-09-30 00:00:00

abstract：:The "some invalid, some valid instrumental variable estimator" (sisVIVE) is a lasso-based method for instrumental variables (IVs) regression of outcome on an exposure. In principle, sisVIVE is robust to some of the IVs in the analysis being invalid, in the sense of being related to the outcome variable through pathway...

journal_title：Statistics in medicine

authors： Bao Y,Clarke PS,Smart M,Kumari M

更新日期：2019-04-30 00:00:00

abstract：:The EQ-5D, a widely used multiattribute utility instrument, is commonly used in health economic evaluations where the goal is to decide on which treatments to reimburse. Like other instruments, value sets of the EQ-5D are constructed using valuation studies typically valuing a subset of the health states and using pre...

journal_title：Statistics in medicine

authors： Shams S,Pullenayegum E

更新日期：2020-10-15 00:00:00

abstract：:Case-control studies are prone to low power for testing gene-environment interactions (GXE) given the need for a sufficient number of individuals on each strata of disease, gene, and environment. We propose a new study design to increase power by strategically pooling biospecimens. Pooling biospecimens allows us to in...

journal_title：Statistics in medicine

authors： Danaher MR,Schisterman EF,Roy A,Albert PS

更新日期：2012-11-20 00:00:00

abstract：:We give up-to-date methods for estimating the age-specific incidence of a disease and for estimating the effect of risk factors. We recommend taking age as the basic time scale of the analysis; then, the hazard function can be interpreted as the age-specific incidence of the disease. This choice raises a delayed entry...

journal_title：Statistics in medicine

authors： Commenges D,Letenneur L,Joly P,Alioum A,Dartigues JF

更新日期：1998-09-15 00:00:00

abstract：:Cox proportional hazard regression model is a popular tool to analyze the relationship between a censored lifetime variable with other relevant factors. The semiparametric Cox model is widely used to study different types of data arising from applied disciplines such as medical science, biology, and reliability studie...

journal_title：Statistics in medicine

authors： Ghosh A,Basu A

更新日期：2019-11-30 00:00:00

abstract：:Biomarkers that predict the efficacy of treatment can potentially improve clinical outcomes and decrease medical costs by allowing treatment to be provided only to those most likely to benefit. We consider the design of a randomized clinical trial in which one objective is to evaluate a treatment selection marker. The...

journal_title：Statistics in medicine

authors： Janes H,Brown MD,Pepe MS

更新日期：2015-11-30 00:00:00

abstract：:Biological drug products are therapeutic moieties manufactured by a living system or organisms. These are important life-saving drug products for patients with unmet medical needs. Because of expensive cost, only a few patients have access to life-saving biological products. Most of the early biological products will ...

journal_title：Statistics in medicine

authors： Lin JR,Chow SC,Chang CH,Lin YC,Liu JP

更新日期：2013-02-10 00:00:00

abstract：:For many HIV-infected patients, use of antiretroviral therapy (ART) results in a sustained suppression of plasma viral load to undetectable levels. However, due to lack of antigenic stimulation, this may also result in a gradual loss of cell-mediated immune (CMI) responses that help control HIV infection. In concept, ...

journal_title：Statistics in medicine

authors： Mogg R,Mehrotra DV

更新日期：2007-02-10 00:00:00

abstract：:Biomedical studies often measure variables with error. Examples in the literature include investigation of the association between the change in some outcome variable (blood pressure, cholesterol level etc.) and a set of explanatory variables (age, smoking status etc.). Typically, one fits linear regression models to ...

journal_title：Statistics in medicine

authors： Yanez ND 3rd,Kronmal RA,Shemanski LR

更新日期：1998-11-30 00:00:00

abstract：:We examine the common clinical belief that there is an interaction between epilepsy type and the two standard anti-epileptic drugs, valproate and carbamazepine, using data from several randomized clinical trials. Epilepsy type is not always easy to define, and three possible reclassifications are investigated to see w...

journal_title：Statistics in medicine

authors： Williamson PR,Clough HE,Hutton JL,Marson AG,Chadwick DW

更新日期：2002-09-30 00:00:00

abstract：:We propose a new design for dose finding for cytotoxic agents in two ordered groups of patients. By ordered groups, we mean that prior to the study there is clinical information that would indicate that for a given dose one group would be more susceptible to toxicities than patients in the other group. The designs are...

journal_title：Statistics in medicine

authors： Conaway MR,Wages NA

更新日期：2017-01-30 00:00:00